Australia markets closed

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.7900-0.8300 (-22.93%)
At close: 04:00PM EDT
2.9000 +0.11 (+3.94%)
Pre-market: 07:23AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
548.721
10,055
5,005
14,039
-
Total cash
548.721
10,055
5,005
14,039
-
Other current assets
839.59
2,509
2,473
1,456
-
Total current assets
1,591
12,565
7,477
15,496
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
-
-
-
-
18.165
Net property, plant and equipment
4.933
5.664
16.109
23.431
-
Total non-current assets
109.683
488.47
1,280
357.569
-
Total assets
1,701
13,053
8,757
15,853
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
300.806
409.968
387.794
439.294
-
Accounts payable
-
3,682
1,981
946.33
289.499
Accrued liabilities
-
828.391
224.949
519.804
21.5
Total current liabilities
6,133
4,920
2,594
1,905
-
Non-current liabilities
Total non-current liabilities
0
0
0
0
-
Total liabilities
6,133
4,920
2,594
1,905
-
Stockholders' equity
Common stock
6.214
1.617
0.949
23.856
-
Retained earnings
-69,567
-50,716
-35,442
-20,946
-
Total stockholders' equity
-4,432
8,133
6,163
13,948
-
Total liabilities and stockholders' equity
1,701
13,053
8,757
15,853
-